What are the different types of hepatitis treatment?
Three types of interferon and two antiviral drugs represent common treatment of hepatitis. Doctors prescribe these drugs or their combination based on the type of hepatitis diagnosed in the patient. Hepatitis B is treated with interferon and lamivudin, while hepatitis C treatment can consist of a combination of interferon and ribavirin. Interferon consists of proteins that stimulate the body's immune cells in the fight against infection. Ribavirin and lamivudin are antiviral drugs that fight infection.
In most cases, hepatitis treatment is engaged in chronic forms of the disease, namely hepatitis B, C and a small percentage of people with hepatitis D. Acute cases of hepatitis B and C usually create several symptoms that decide within six months.
interferon hepatitis could function half the eligible patients because relaps are common. Between bInterest side effects of interferon include symptoms similar to flu, which are usually smaller. Oral lamivudin is usually prescribed for one year and can cause liver and blood disorders in rare cases. Ribavirin may slow down the production of blood cells and plates when using hepatitis. It is not prescribed for men or women who plan to have children because it can cause innate defects.
Anyone exposed to non -hygienic food procedures can be infected by hepatitis A. This may occur after consuming food or water contaminated with fecal matter and after consuming raw or insufficiently cooked molluscs. Traveling to areas where the disease does not control can also spread the disease, but can be prevented through vaccines. Children rarely show symptoms of hepatitis A, but adults can suddenly feel sick and suffer jaundice. Hepatitis treatment is generally not necessary for this straina virus that is usually resolved in a few months.
chronic cases of hepatitis B and hepatitis C usually require treatment to prevent permanent liver damage and reduce the risk of liver cancer. These disorders are spreading by sharing dirty needles, sexual contact with an infected person and blood transfusions before starting screening on hepatitis. Any situation where a person comes into contact with blood or body fluids infected with a virus is a risk.
There are no treatment options for the treatment of chronic hepatitis E, which may lead to liver or cancer cirrhosis. Most often they emerge after traveling to countries where hepatitis infections are high. This type of virus could spread by unclean dental or medical instruments or from injuries that break the skin and will be contaminated. Interferon can help a small percentage of patients infected with hepatitis B and hepatitis D.